A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma. (2017)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/his.13194
PubMed Identifier: 28226180
Publication URI: http://europepmc.org/abstract/MED/28226180
Type: Journal Article/Review
Volume: 71
Parent Publication: Histopathology
Issue: 1
ISSN: 0309-0167